11 news items
Atossa Therapeutics Announces Support Of New Breast Cancer Screening Guidelines
ATOS
7 May 24
announced its support of new guidelines released by the U.S. Preventive Services Task Force (USPSTF) recommending that women begin breast cancer
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
and Company, in women with ER+/HER2- breast cancer. Set to enroll approximately 20 newly diagnosed women, the new study arm will have participants
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
Lilly and Company, in women with ER+/HER2- breast cancer. Set to enroll approximately 20 newly diagnosed women, the new study arm will have
Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
ATOS
29 Apr 24
. Atossa's (Z)-endoxifen has been shown to be well tolerated in Phase 1 studies and in a small Phase 2 study of women with breast cancer. (Z
Atossa Therapeutics And Quantum Leap Healthcare Initiates I-SPY 2 Clinical Trial To Evaluate (Z)-Endoxifen In Combination With Abemaciclib In Women With ER+/HER2- Breast Cancer
ATOS
15 Apr 24
The new study arm will enroll approximately 20 women with newly diagnosed Estrogen Receptor positive (ER+) / Human Epidermal Growth Factor
8svbq25xk21k6cssgq1yx80m4us
ATOS
15 Apr 24
in combination with abemaciclib (VERZENIO®), a cyclin-dependent kinase (CDK) 4/6 inhibitor marketed by Eli Lilly and Company, in women
5ka6zrh4v an6o636
ATOS
9 Apr 24
The EVANGELINE study is evaluating (Z)-endoxifen as a neoadjuvant treatment for pre-menopausal women with Grade 1 or 2 Estrogen Receptor positive
lncebhnm zu3j2
ATOS
9 Apr 24
. The EVANGELINE study is evaluating (Z)-endoxifen as a neoadjuvant treatment for pre-menopausal women with Grade 1 or 2 Estrogen Receptor positive (ER
rk2874uv5hnp2nkn3h7cdx5bx2it2nw0jwllpr
ATOS
1 Apr 24
: Full enrollment of Phase 2 Karisma-Endoxifen Clinical Trial – the study is investigating (Z)-endoxifen in premenopausal women
1v8nxqjuyz5oozrxfb45oi6f qu18scr85ol6sh0y3o5bmnd3o5vag0enxqx
ATOS
12 Mar 24
diagnosed with the disease. While progress has been made over the past decade, breast cancer remains a deadly disease for hundreds of thousands of women
vn4t7nmm3q5ndff635dvlzqev6bz2 u0blxqaib9or9
ATOS
22 Feb 24
platform study designed to offer women diagnosed with DCIS six months of neoadjuvant endocrine therapy with the intent of determining their suitability
- Prev
- 1
- Next